Travere Therapeutics, Inc. · NASDAQ:TVTX

Coughlin Timothy sold 3,250 Travere Therapeutics, Inc. shares (Form 4)

Traded May 15, 2026 · Filed May 19, 2026

On May 15, 2026, Coughlin Timothy (Director) sold 3,250 Travere Therapeutics, Inc. shares at US$43.49 for US$141K under a trading plan, leaving 52,250 shares. Filed May 19, 2026 (Form 4).

Sold
3,250 shares
Price
US$43.49
Value
US$141K
Holding after
52,250 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 15, 2026Common StockSale3,250US$43.4952,250Direct

Source

View original at SEC

Related